Natural Product Target Network Reveals Potential for Cancer Combination Therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natural Product Target Network Reveals Potential for Cancer Combination Therapies

Published:2019-05-31 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Chamberlin Steven R.,Blucher Aurora,Wu Guanming,Shinto Lynne,Choonoo Gabrielle,Kulesz-Martin Molly,McWeeney Shannon

Funder

U.S. National Library of Medicine

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference67 articles.

1. Combinatorial drug therapy for cancer in the post-genomic era;Al-Lazikani;Nat. Biotechnol.,2012

2. Network systems biology for drug discovery;Arrell;Clin. Pharmacol. Ther.,2010

3. Regulatory network motifs and hotspots of cancer genes in a mammalian cellular signalling network;Awan;IET Syst. Biol.,2007

4. The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression;Becker;Cell Death Dis.,2014

5. The control of the false discovery rate in multiple testing under dependency;Benjamini;Ann. Stat.,2001

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Selectivity and Inhibitory Effects of Chemotherapy Drugs Against Myelogenous Leukemia Cells with Lippia alba Essential Oil Enriched in Citral;International Journal of Molecular Sciences;2024-08-16

2. Fatty Acid Amides Suppress Proliferation via Cannabinoid Receptors and Promote the Apoptosis of C6 Glioma Cells in Association with Akt Signaling Pathway Inhibition;Pharmaceuticals;2024-07-02

3. Revisiting the antioxidant-prooxidant conundrum in cancer research;Medical Oncology;2024-06-19

4. Zingiber officinale promotes autophagy and apoptosis in human oral cancer through the C/EBP homologous protein;Cancer Science;2024-06-18

5. Combating anoikis resistance: bioactive compounds transforming prostate cancer therapy;Anti-Cancer Drugs;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3